{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:33:41Z","timestamp":1793122421644,"version":"4.5.0"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:00:00Z","timestamp":1790985600000},"content-version":"vor","delay-in-days":275,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,29]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Complement-mediated thrombotic microangiopathy (CM-TMA) is often triggered by autoimmune diseases; however, reports of CM-TMA in patients with Sj\u00f6gren disease and idiopathic inflammatory myopathy are limited. We describe the case of a 48-year-old woman with overlapping Sj\u00f6gren disease and idiopathic inflammatory myopathy who presented with interstitial lung disease. After the initiation of combination therapy with a calcineurin inhibitor, intravenous cyclophosphamide, and glucocorticoids, she developed progressive thrombocytopenia with schistocytosis, haemolytic anaemia, and acute renal dysfunction. Laboratory testing revealed preserved disintegrin-like and metalloproteinase with thrombospondin type 1 motifs 13 (ADAMTS13) activity (49%) with negative ADAMTS13 inhibitor and Shiga toxins. Despite therapeutic plasma infusion and plasma exchange, she developed severe cardiac dysfunction and abdominal pain, with progressive haematologic and renal dysfunctions requiring haemodialysis. Based on a clinical diagnosis of CM-TMA, eculizumab was initiated, resulting in gradual improvement in haemolysis markers and platelet counts. However, she developed severe multiorgan complications, including a cerebellar haemorrhage, acute pancreatitis, and coagulopathy, and ultimately died. Genetic testing performed during the clinical course identified a complement factor B p.Arg74His variant. This case represents an instance of CM-TMA associated with a Sj\u00f6gren disease\/idiopathic inflammatory myopathy overlap and a complement factor B variant of uncertain pathogenic significance, suggesting that multiple converging factors may contribute to CM-TMA development.<\/jats:p>","DOI":"10.1093\/mrcr\/rxag097","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T11:53:23Z","timestamp":1790855603000},"source":"Crossref","is-referenced-by-count":0,"title":["Sj\u00f6gren disease and idiopathic inflammatory myopathy overlap presenting as complement-mediated thrombotic microangiopathy\/atypical haemolytic uremic syndrome with a complement factor B variant: A case report"],"prefix":"10.1093","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-7520-9762","authenticated-orcid":false,"given":"Momoka","family":"Hasegawa","sequence":"first","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences , Okayama ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6981-3443","authenticated-orcid":false,"given":"Yoshia","family":"Miyawaki","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences , Okayama ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1180-4405","authenticated-orcid":false,"given":"Moe","family":"Sakamoto-Tokunaga","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences , Okayama ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Matoba","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences , Okayama ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumi","family":"Maeda","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences , Okayama ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomokazu","family":"Tamura","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences , Okayama ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7283-9660","authenticated-orcid":false,"given":"Natsuki","family":"Kubota","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences , Okayama ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0242-3740","authenticated-orcid":false,"given":"Yuya","family":"Terajima","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences , Okayama ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7050-1862","authenticated-orcid":false,"given":"Kei","family":"Hirose","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences , Okayama ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8072-0830","authenticated-orcid":false,"given":"Kazuya","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences , Okayama ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manami","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences , Okayama ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3217-8028","authenticated-orcid":false,"given":"Takato","family":"Nakadoi","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences , Okayama ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3199-1905","authenticated-orcid":false,"given":"Shoichi","family":"Nawachi","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences , Okayama ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2935-6284","authenticated-orcid":false,"given":"Keigo","family":"Hayashi","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences , Okayama ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7837-086X","authenticated-orcid":false,"given":"Haruki","family":"Watanaebe","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences , Okayama ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2018-3647","authenticated-orcid":false,"given":"Eri","family":"Katsuyama","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences , Okayama ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7159-5537","authenticated-orcid":false,"given":"Takayuki","family":"Katsuyama","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences , Okayama ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Narazaki","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences , Okayama ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7047-2976","authenticated-orcid":false,"given":"Yoshinori","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences , Okayama ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7322-5460","authenticated-orcid":false,"given":"Noboru","family":"Asada","sequence":"additional","affiliation":[{"name":"Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences , Okayama ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3924-6887","authenticated-orcid":false,"given":"Noritoshi","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Nagoya University, Graduate School of Medicine , Nagoya, Aichi ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1468-5170","authenticated-orcid":false,"given":"Jun","family":"Wada","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences , Okayama ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,10,3]]},"reference":[{"key":"2026102712520045100_ref1","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1159\/000544724","article-title":"Microangiopathic anemia","volume":"52","author":"Bommer","year":"2025","journal-title":"Transfus Med Hemother"},{"key":"2026102712520045100_ref2","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1159\/000508920","article-title":"Atypical hemolytic uremic syndrome: new challenges in the complement blockage era","volume":"144","author":"Avila Bernabeu","year":"2020","journal-title":"Nephron"},{"key":"2026102712520045100_ref3","doi-asserted-by":"crossref","first-page":"1088031","DOI":"10.3389\/fphar.2022.1088031","article-title":"Drug-induced thrombotic microangiopathy: an updated review of causative drugs, pathophysiology, and management","volume":"13","author":"Mazzierli","year":"2022","journal-title":"Front Pharmacol"},{"key":"2026102712520045100_ref4","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000445127","article-title":"Comprehensive analysis of complement genes in patients with atypical hemolytic uremic syndrome","volume":"43","author":"Zhang","year":"2016","journal-title":"Am J Nephrol"},{"key":"2026102712520045100_ref5","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1159\/000547975","article-title":"A complement factor B mutation in a Chinese family with atypical hemolytic uremic syndrome: a case report and systematic review","volume":"15","author":"Peng","year":"2025","journal-title":"Case Rep Nephrol Dial"},{"key":"2026102712520045100_ref6","doi-asserted-by":"crossref","first-page":"1568082","DOI":"10.3389\/fendo.2025.1568082","article-title":"Real-world effectiveness of eculizumab in atypical hemolytic uremic syndrome: a retrospective study from Western China","volume":"16","author":"Hu","year":"2025","journal-title":"Front Endocrinol"},{"key":"2026102712520045100_ref7","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1007\/s00296-024-05558-9","article-title":"Systemic lupus erythematosus presenting with atypical hemolytic uremic syndrome: a case report and review of the literature","volume":"44","author":"Smith","year":"2024","journal-title":"Rheumatol Int"},{"key":"2026102712520045100_ref8","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1093\/ndt\/gfw453","article-title":"Eculizumab in secondary atypical haemolytic uraemic syndrome","volume":"32","author":"Cavero","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"2026102712520045100_ref9","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000004459","article-title":"Complement activation and effect of eculizumab in scleroderma renal crisis","volume":"95","author":"Devresse","year":"2016","journal-title":"Medicine"},{"key":"2026102712520045100_ref10","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.semarthrit.2018.11.005","article-title":"Secondary thrombotic microangiopathy in systemic lupus erythematosus and antiphospholipid syndrome, the role of complement and use of eculizumab: case series and review of literature","volume":"49","author":"Kello","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"2026102712520045100_ref11","first-page":"16385","article-title":"Atypical hemolytic-uremic syndrome due to scleroderma renal crisis treated with eculizumab","volume":"133","author":"Skonieczny","year":"2023","journal-title":"Pol Arch Intern Med"},{"key":"2026102712520045100_ref12","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.ekir.2021.01.021","article-title":"Role of C5 inhibition in idiopathic inflammatory myopathies and scleroderma renal crisis-induced thrombotic microangiopathies","volume":"6","author":"Gouin","year":"2021","journal-title":"Kidney Int Rep"},{"key":"2026102712520045100_ref13","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1002\/art.40320","article-title":"2017 European League Against Rheumatism\/American College of Rheumatology Classification Criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"69","author":"Lundberg","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2026102712520045100_ref14","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1136\/annrheumdis-2016-210448","article-title":"Standardisation of labial salivary gland histopathology in clinical trials in primary Sj\u00f6gren's syndrome","volume":"76","author":"Fisher","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2026102712520045100_ref15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/annrheumdis-2016-210571","article-title":"2016 American College of Rheumatology\/European League Against Rheumatism classification criteria for primary Sj\u00f6gren's syndrome: a consensus and data-driven methodology involving three international patient cohorts","volume":"76","author":"Shiboski","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2026102712520045100_ref16","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3109\/s10165-004-0338-x","article-title":"Revised Japanese criteria for Sj\u00f6gren's syndrome (1999): availability and validity","volume":"14","author":"Fujibayashi","year":"2004","journal-title":"Mod Rheumatol"},{"key":"2026102712520045100_ref17","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1093\/rheumatology\/keab423","article-title":"Significance of Sj\u00f6gren's syndrome and anti-cN1A antibody in myositis patients","volume":"61","author":"Levy","year":"2022","journal-title":"Rheumatology"},{"key":"2026102712520045100_ref18","doi-asserted-by":"crossref","first-page":"1020113","DOI":"10.3389\/fneur.2022.1020113","article-title":"Inclusion body myositis: update on the diagnostic and therapeutic landscape","volume":"13","author":"Naddaf","year":"2022","journal-title":"Front Neurol"},{"key":"2026102712520045100_ref19","first-page":"457","article-title":"Myositis in primary Sj\u00f6gren's syndrome: data from a multicentre cohort","volume":"33","author":"Colafrancesco","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"2026102712520045100_ref20","first-page":"717","article-title":"Subclinical myositis is common in primary Sj\u00f6gren's syndrome and is not related to muscle pain","volume":"29","author":"Lindvall","year":"2002","journal-title":"J Rheumatol"},{"key":"2026102712520045100_ref21","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1007\/s40620-025-02425-z","article-title":"Iptacopan\/LNP023 and rituximab as rescue therapy in a patient with systemic lupus erythematosus-associated atypical haemolytic uraemic syndrome","volume":"38","author":"Benvenuti","year":"2025","journal-title":"J Nephrol"},{"key":"2026102712520045100_ref22","doi-asserted-by":"crossref","first-page":"omaa048","DOI":"10.1093\/omcr\/omaa048","article-title":"Atypical hemolytic uremic syndrome with peripheral gangrene and homocysteinemia in a child","volume":"2020","author":"Al-Ahmad","year":"2020","journal-title":"Oxf Med Case Rep"},{"key":"2026102712520045100_ref23","author":"National Center for Biotechnology Information"},{"key":"2026102712520045100_ref24","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s13075-022-02860-4","article-title":"The potential roles of type I interferon activated neutrophils and neutrophil extracellular traps (NETs) in the pathogenesis of primary Sj\u00f6gren's syndrome","volume":"24","author":"Peng","year":"2022","journal-title":"Arthritis Res Ther"},{"key":"2026102712520045100_ref25","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.134189","article-title":"Neutrophil dysregulation is pathogenic in idiopathic inflammatory myopathies","volume":"5","author":"Seto","year":"2020","journal-title":"JCI Insight"},{"key":"2026102712520045100_ref26","doi-asserted-by":"crossref","first-page":"5626","DOI":"10.3390\/ijms23105626","article-title":"Endothelial dysfunction induced by extracellular neutrophil traps plays important role in the occurrence and treatment of extracellular neutrophil traps-related disease","volume":"23","author":"Yu","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2026102712520045100_ref27","author":"Genome Aggregation Database (gnomAD)"}],"container-title":["Modern Rheumatology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mrcr\/advance-article-pdf\/doi\/10.1093\/mrcr\/rxag097\/71576999\/rxag097.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mrcr\/article-pdf\/10\/2\/rxag097\/71576999\/rxag097.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mrcr\/article-pdf\/10\/2\/rxag097\/71576999\/rxag097.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:52:12Z","timestamp":1793119932000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mrcr\/article\/doi\/10.1093\/mrcr\/rxag097\/8860308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6,29]]}},"URL":"https:\/\/doi.org\/10.1093\/mrcr\/rxag097","relation":{},"ISSN":["2472-5625"],"issn-type":[{"value":"2472-5625","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026]]},"published":{"date-parts":[[2026]]},"article-number":"rxag097"}}